111 completed, 12 unknown, 10 terminated, 5 active not recruiting. 44 Phase 4, 39 Phase 2, 33 Phase 3, 14 Not applicable, 14 Phase 1.
Follow Teriparatide: new trials by email Literature Review of Teriparatide trials Research Report on Teriparatide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PROactive HEALing in High-Risk Pelvic and Non-hip Lower Extremity Fragility Fractures (PRO HEAL Pilot) subcutaneous Teriparatide injection - Lower Extremity Fractures, Pelvis | Phase 1 / Phase 2 | Not yet recruiting | University of Calgary | 54 | 2027-03-15 | 2026-10-06 |
| A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants Forsteo®, B-3E07 - Healthy Volunteers | Phase 1 | Recruiting | Syneos Health | 48 | 2026-04-10 | 2026-07-16 |
| Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis Alendronate, Ibandronate; Risedronate, Teriparatide - Osteoporosis, Osteoporosis, Postmenopausal | Not applicable | Completed | Khyber Medical University Peshawar | 40 | 2025-10-01 | 2026-08-13 |
| To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture QLG2128, Teriparatide Injection - Postmenopausal Women With Osteoporosis | Phase 3 | Not yet recruiting | Qilu Pharmaceutical Co., Ltd. | 282 | 2025-06-01 | 2025-03-27 |
| Combined Anabolic Therapy Romosozumab, Teriparatide - Osteoporosis, Postmenopausal, Osteoporosis | Phase 4 | Recruiting | Massachusetts General Hospital | 50 | 2025-02-03 | 2026-10-08 |
| Precision Medicine Approach for Osteoporosis - Follow Up Study Alendronate, Teriparatide - Osteoporosis | Phase 4 | Enrolling by invitation | Paul F Netzel | 40 | 2024-02-01 | 2026-04-01 |
| Sequential Therapies After Osteoanabolic Treatment Zoledronate, Denosumab, Teriparatide - Osteoporosis, Postmenopausal | Recruiting | 424 General Military Hospital | 150 | 2023-11-25 | 2026-07-22 | |
| Teriparatide on Maxillary Sinus Floor Osseointegration Teriparatide, Maxillary Sinus Augmentation, Dental Implant Installation - Bone Regeneration | Phase 4 | Unknown | Universidad de Valparaiso | 42 | 2023-08-23 | 2023-11-30 |
| Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture Denosumab, Teriparatide - Osteoporotic Fractures | Not applicable | Recruiting | Peking Union Medical College Hospital | 2478 | 2023-05-26 | 2026-01-12 |
| Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo EBP05, Forteo 0.02 mg, EBP11 - Hypoparathyroidism, Osteoporosis | Phase 1 | Completed | Entera Bio Ltd. | 45 | 2023-05-11 | 2026-02-17 |
| Fracture Recovery for Returning to Duty (Teriparatide STRONG) Teriparatide, Placebos - Stress Fracture of Tibia or Fibula | Phase 4 | Enrolling by invitation | University of South Carolina | 183 | 2022-12-08 | 2023-02-13 |
| Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover Teriparatide, Alendronate - Age-Related Osteoporosis | Phase 4 | Active not recruiting | Madhumathi Rao | 60 | 2022-03-21 | 2026-05-14 |
| Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule RT-102 (80 μg), Forteo, RT-102 (20 μg) - Healthy Volunteers | Phase 1 | Completed | RANI Therapeutics | 50 | 2022-02-21 | 2022-10-31 |
| Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease Teriparatide, DXA,VFA, X-ray, HR-pQCT, 18-F NAF PET/CT, Bone biopsy - Adynamic Bone Disease, Chronic Kidney Diseases | Phase 4 | Recruiting | Ditte Hansen | 48 | 2021-12-15 | 2024-04-23 |
| To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk SAL056 (56.5μg), Alendronate - Postmenopausal Women With Osteoporosis | Phase 3 | Completed | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 493 | 2021-12-03 | 2025-06-25 |
| Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women Abaloparatide, Teriparatide - Osteoporosis, Postmenopausal | Completed | Radius Health, Inc. | 22054 | 2021-07-01 | 2024-04-19 | |
| Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes Teriparatide - Stress Fracture | Phase 3 | Completed | Norfolk and Norwich University Hospitals NHS Foundation Trust | 30 | 2021-05-24 | 2021-08-12 |
| Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa). Teriparatide - Secondary Hyperparathyroidism, Chronic Kidney Disease-Mineral and Bone Disorder | Phase 3 | Completed | Saint Petersburg State University, Russia | 20 | 2021-03-01 | 2022-11-10 |
| Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging Vitamin K (MK7), Teriparatide - Bone Metabolism Disorder, Aging Disorder | Not applicable | Terminated | University of Milano Bicocca | 99 | 2020-11-24 | 2025-07-29 |
| Replication of the VERO Osteoporosis Trial in Healthcare Claims Data Teriparatide, Risedronate - Osteoporosis | Completed | Brigham and Women's Hospital | 12757 | 2020-10-29 | 2023-07-27 |
Showing 20 of 152. Sign in to see all of them.
Osteoporosis (79) · Osteoporosis, Postmenopausal (35) · Bone Diseases, Metabolic (19) · Fractures, Bone (6) · Hypoparathyroidism (6) · Osteoporotic Fractures (5) · Fractures, Stress (3) · Hip Fractures (3) · Osteogenesis Imperfecta (3) · Spinal Cord Injuries (3) · Spinal Fractures (3) · Back Pain (2) · Bone Diseases (2) · Chronic Kidney Disease-Mineral and Bone Disorder (2) · Femoral Neck Fractures (2)
Eli Lilly and Company (37) · Massachusetts General Hospital (7) · Entera Bio Ltd. (5) · Medical University of Vienna (4) · Radius Health, Inc. (3) · University Health Network, Toronto (3) · University Hospital, Linkoeping (3) · 424 General Military Hospital (2) · Amgen (2) · Brigham and Women's Hospital (2) · Columbia University (2) · Helen Hayes Hospital (2) · Nottingham University Hospitals NHS Trust (2) · Novartis (2) · Pfenex, Inc (2)
United States (72) · Canada (15) · Denmark (13) · Germany (11) · United Kingdom (10) · Argentina (9) · Greece (9) · Israel (9) · Italy (9) · Spain (9) · Austria (8) · Belgium (8) · Czechia (8) · Mexico (8) · Poland (7)
Benjamin Leder, MD (3) · Yosef Caraco, MD (3) · Adi Cohen, MD (2) · Christian Muschitz, M.D. (2) · Elizabeth Shane, MD (2) · Thomas J Schnitzer, MD, PhD (2) · Agnes Linglart, MD, PhD (1) · Angela M Cheung, MD, PhD (1) · Angela MW Cheung, MD, PhD (1) · Angela Rogers, BSc (Hons), PhD, MCSP (1) · Angus Wallace (1)
PMID 19594305, PMID 34231877, PMID 18003959, PMID 18838053, PMID 19250060, PMID 19401368, PMID 19584192, PMID 19656016, PMID 19858319, PMID 19918047, PMID 19929434, PMID 20367417, PMID 20580870, PMID 20950166, PMID 21555774, PMID 21593114, PMID 22766223, PMID 23099796, PMID 23149277, PMID 23186957, PMID 23234813, PMID 23322362, PMID 23543660, PMID 23683600, PMID 23719683, PMID 24382002, PMID 24420643, PMID 24463451, PMID 24619763, PMID 24684466, PMID 25393645, PMID 25933031, PMID 26144908, PMID 26179771, PMID 26185429, PMID 26358172, PMID 26841258, PMID 26964731, PMID 27111239, PMID 27533157, PMID 27612281, PMID 27826127, PMID 28544807, PMID 29024120, PMID 29129436, PMID 29329484, PMID 29365099, PMID 29548300, PMID 29972871, PMID 30102789
2009 (2), 2016 (2), 2008 (1), 2015 (1), 2018 (1), N01AR002245 (1), P50AR039191 (1), P50AR044855 (1), P50AR054041 (1), R01AG072797 (1), R01AR041443 (1), R01AR056651 (1), R01AR059204 (1), R01AR073191 (1), R01DK051081 (1)